Skip to main content

Market Overview

42 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) jumped 215 percent to $8.28 after the company disclosed that it has achieved its primary endpoint in its Phase 2 trial for major depressive disorder..
  • Luxoft Holding, Inc. (NYSE: LXFT) climbed 81.4 percent to $57.50 after the company announced it is being acquired by DXC for $2 billion.
  • Loxo Oncology, Inc. (NASDAQ: LOXO) gained 65.6 percent to $231.63 after the company received an acquisition offer from Eli Lilly (NYSE: LLY) at $235/Share in cash.
  • Sage Therapeutics, Inc. (NASDAQ: SAGE) gained 44.6 percent to $140.99 after the company disclosed that its SAGE-217 met its primary and secondary endpoints in its Phase 3 clinical trial in postpartum depression.
  • QEP Resources, Inc. (NYSE: QEP) gained 43.1 percent to $8.70 after Elliott Management made an offer to acquire the company.
  • Insmed Incorporated (NASDAQ: INSM) jumped 41.1 percent to $20.95 after climbing 6.76 percent on Friday.
  • Phunware Inc (NASDAQ: PHUN) gained 35 percent to $73.00.
  • Taiwan Liposome Company, Ltd. (NASDAQ: TLC) rose 28.3 percent to $7.70.
  • CLPS Inc (NASDAQ: CLPS) gained 23.5 percent to $3.10.
  • Leap Therapeutics, Inc. (NASDAQ: LPTX) surged 23.4 percent to $3.16.
  • ION Geophysical Corporation (NYSE: IO) gained 23 percent to $7.38.
  • Roku, Inc. (NASDAQ: ROKU) gained 22.4 percent to $41.21 after the company reported estimated Q4 active accounts have increased since last year and streaming hours are up 68%. The company also announced a partnership with Westinghouse.
  • Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose 22 percent to $71.98. Reata Pharmaceuticals named Geoffrey A. Block, M.D., as Vice President, Nephrology.
  • Merus N.V. (NASDAQ: MRUS) jumped 20.9 percent to $17.04 after reporting IND clearance for MCLA-145.
  • Lannett Company, Inc. (NYSE: LCI) rose 20.4 percent to $7.31.
  • Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) jumped 19.5 percent to $3.2025.
  • Selecta Biosciences, Inc. (NASDAQ: SELB) rose 19 percent to $2.88.
  • ASV Holdings Inc (NASDAQ: ASV) gained 18 percent to $3.15.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) jumped 17.3 percent to $21.51 after reporting product revenue for Q4 and 2018.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) gained 17.2 percent to $62.67.
  • Invitae Corporation (NYSE: NVTA) surged 17.2 percent to $13.69 after reporting 2018 preliminary financial results.
  • Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) climbed 16.7 percent to $6.20.
  • Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) rose 15.1percent to $3.2352.
  • SilverSun Technologies, Inc. (NASDAQ: SSNT) rose 15 percent to $2.2999.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) gained 14.4 percent to $24.57.
  • Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 13.5 percent to $3.28 after the company disclosed that it has received its Canada Cannabis license.
  • Exact Sciences Corporation (NASDAQ: EXAS) rose 12.6 percent to $73.92 after the company issued strong revenue forecast.
  • Diebold Nixdorf, Incorporated (NYSE: DBD) rose 11.8 percent to $2.94 after dropping 2.59 percent on Friday.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) climbed 10.9 percent to $3.58.
  • Neurocrine Biosciences, Inc. (NASDAQ: NBIX) gained 9.1 percent to $81.46 after the company announced it expects Q4 net product sales to have doubled since last year.
  • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) gained 6.1 percent to $43.47.
  • General Electric Company (NYSE: GE) shares rose 6 percent to $8.71 following reports that Apollo is considering GE's jet-leasing business.

Check out these big penny stock gainers and losers

Losers

  • Natural Health Trends Corp. (NASDAQ: NHTC) fell 23.9 percent to $15.05. Natural Health Trends rejected false allegations in CCTV report and reiterated commitment to ethical business practices.
  • AxoGen, Inc. (NASDAQ: AXGN) dropped 21.2 percent to $16.79. AxoGen expects Q4 sales of at least $23.4 million and FY18 sales of at least $83.9 million.
  • PG&E Corporation (NYSE: PCG) dropped 20.6 percent to 19.36 after CNBC reported the company could face a minimum of $30 billion in liabilities related to California wildfires in 2017 and 2018, citing unnamed sources.The report comes after a Reuters story over the weekend suggested the utility is considering a bankruptcy filing and will potentially be taking a major financial charge in Q4.
  • Collegium Pharmaceutical, Inc. (NASDAQ: COLL) shares dipped 19.4 percent to $15.09 after the company issued full-year 2019 guidance.
  • Cutera, Inc. (NASDAQ: CUTR) dropped 18.2 percent to $13.85 after reporting resignation of CEO and President James Reinstein.
  • Maxar Technologies Ltd. (NYSE: MAXR) fell 18.2 percent to $9.59 after the company reported failure of its WorldView-4 Satellite.
  • Hi-Crush Partners LP (NYSE: HCLP) tumbled 15 percent to $3.6900 after the company reported Q4 sales volumes fell 29% Q/Q and suspended its quarterly distribution.
  • MOGU Inc. (NYSE: MOGU) fell 11.2 percent to $18.82 after dropping 6.70 percent on Friday.
  • FTE Networks, Inc. (NYSE: FTNW) dropped 11 percent to $3.3750.
  • Select Medical Holdings Corporation (NYSE: SEM) fell 10.3 percent to $14.43.
 

Related Articles (ARNA + ASV)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com